TheJobsMap
NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) logo

NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) jobs and careers

nurexone.comLinkedIn@NBiologic

About NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90)

NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System. The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.

BiotechnologyHealth CareLife SciencesNeuroscienceRehabilitationTherapeuticsBiopharmaClinical Trials
Founded
2020
Employees
11 to 50
Total funding
$995K

Leadership

The top of NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90)'s org chart, with how many people report into each leader.

LSPhoto of Lior Shaltiel

Lior Shaltiel

CEO

11 reports

TK

Tali Kizhner

RD Director

8 reports

EOPhoto of Eran Ovadya

Eran Ovadya

Chief Financial Officer

1 report

Jobs at NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90)

No open positions right now. Explore more companies on TheJobsMap.